Herbert Opitz

469 total citations
6 papers, 278 citations indexed

About

Herbert Opitz is a scholar working on Genetics, Hematology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Herbert Opitz has authored 6 papers receiving a total of 278 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Genetics, 5 papers in Hematology and 2 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Herbert Opitz's work include Hemoglobinopathies and Related Disorders (6 papers), Iron Metabolism and Disorders (5 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers). Herbert Opitz is often cited by papers focused on Hemoglobinopathies and Related Disorders (6 papers), Iron Metabolism and Disorders (5 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers). Herbert Opitz collaborates with scholars based in Switzerland, Italy and Greece. Herbert Opitz's co-authors include J. Ford, Maria Domenica Cappellini, Antonietta Zappu, Renzo Galanello, Antonio Piga, Nicola Hewson, Laura Zanaboni, Daniele Alberti, Romain Séchaud and Antonella Lavagetto and has published in prestigious journals such as Blood and PubMed.

In The Last Decade

Herbert Opitz

6 papers receiving 263 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Herbert Opitz Switzerland	6	243	239	66	30	12	6	278
Michele Rizzo Italy	7	270 1.1×	256 1.1×	63 1.0×	48 1.6×	6 0.5×	14	330
MJ Pippard United Kingdom	6	265 1.1×	254 1.1×	64 1.0×	67 2.2×	7 0.6×	8	334
Filippo Cassarà Italy	7	127 0.5×	114 0.5×	59 0.9×	14 0.5×	11 0.9×	21	164
Maria Sitarou Cyprus	7	214 0.9×	172 0.7×	68 1.0×	18 0.6×	12 1.0×	15	261
Gunay Aliyeva Azerbaijan	6	106 0.4×	93 0.4×	30 0.5×	8 0.3×	5 0.4×	17	149
Ioanna Tzoumari Greece	3	245 1.0×	229 1.0×	77 1.2×	28 0.9×	2 0.2×	6	270
Susan E. Stuber United States	8	335 1.4×	302 1.3×	95 1.4×	15 0.5×	16 1.3×	30	362
J Arlet France	4	82 0.3×	61 0.3×	25 0.4×	5 0.2×	6 0.5×	14	123
Corien L. Eckhardt Netherlands	12	78 0.3×	331 1.4×	43 0.7×	10 0.3×	1 0.1×	23	399
Dalia Mahmoud United States	7	60 0.2×	113 0.5×	13 0.2×	6 0.2×	4 0.3×	16	157

Countries citing papers authored by Herbert Opitz

Since Specialization

Citations

This map shows the geographic impact of Herbert Opitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Herbert Opitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Herbert Opitz more than expected).

Fields of papers citing papers by Herbert Opitz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Herbert Opitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Herbert Opitz. The network helps show where Herbert Opitz may publish in the future.

Co-authorship network of co-authors of Herbert Opitz

This figure shows the co-authorship network connecting the top 25 collaborators of Herbert Opitz. A scholar is included among the top collaborators of Herbert Opitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Herbert Opitz. Herbert Opitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Piga, Antonio, Renzo Galanello, Gian Luca Forni, et al.. (2006). Randomized phase II trial of deferasirox (Exjade, ICL670), a once-daily, orally-administered iron chelator, in comparison to deferoxamine in thalassemia patients with transfusional iron overload.. PubMed. 91(7). 873–80. 226 indexed citations

2.

Cappellini, Maria Domenica, Mohamed Béjaoui, Leyla Ağaoğlu, et al.. (2005). Patient Satisfaction with Deferasirox (Exjade®, ICL670) an Oral Form of Chelation Therapy Versus Deferoxamine an Infused Chelation Therapy.. Blood. 106(11). 2704–2704. 12 indexed citations

3.

Cohen, Alan R., Giuseppe Masera, N. Zoumbos, et al.. (2005). Effect of Iron Intake on Control of Body Iron in Patients with Thalassemia Major Treated with Deferasirox (Exjade®, ICL670).. Blood. 106(11). 822–822. 9 indexed citations

4.

Deugnier, Yves, Bruno Turlin, Martine Ropert, et al.. (2005). Semi-Quantitative Assessment of Hemosiderin Distribution Accurately Reflects Reductions in Liver Iron Concentration Following Therapy with Deferasirox (Exjade®, ICL670) or Deferoxamine in Patients with Transfusion-Dependent Anemia.. Blood. 106(11). 2708–2708. 8 indexed citations

5.

Porter, John B., Caterina Borgna‐Pignatti, Michele Baccarani, et al.. (2005). Iron Chelation Efficiency of Deferasirox (Exjade®, ICL670) in Patients with Transfusional Hemosiderosis.. Blood. 106(11). 2690–2690. 16 indexed citations

6.

Cappellini, Maria Domenica, Mohamed Béjaoui, Silverio Perrotta, et al.. (2004). Phase III Evaluation of Once-Daily, Oral Therapy with ICL670 (Exjade®) Versus Deferoxamine in Patients with β-Thalassemia and Transfusional Hemosiderosis.. Blood. 104(11). 3619–3619. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact